New drug trial aims to ease skin hardening in rare autoimmune disease

NCT ID NCT04789850

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether itacitinib is safe and effective for adults with systemic sclerosis, a disease that causes skin thickening and organ damage. About 74 participants with early or active disease will receive the drug or a placebo for one year. The main goal is to see if it reduces skin thickness, measured by a standard scoring method.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SYSTEMIC SCLEROSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Ambroise Paré hospital

    RECRUITING

    Boulogne-Billancourt, 92100, France

  • Avicenne Hospital

    RECRUITING

    Bobigny, 93022, France

  • CH Amiens

    RECRUITING

    Amiens, 80000, France

  • CH Dax-Côte d'ARgent

    RECRUITING

    Dax, 40100, France

  • CH Le Mans

    RECRUITING

    Le Mans, 72037, France

  • CH Valenciennes

    RECRUITING

    Valenciennes, 59300, France

  • CH de Cornouaille

    RECRUITING

    Quimper, 29000, France

  • CHU Angers

    RECRUITING

    Angers, 49100, France

  • CHU Annecy

    RECRUITING

    Annecy, 74370, France

  • CHU Besançon

    RECRUITING

    Besançon, 25030, France

  • CHU Bordeaux

    RECRUITING

    Bordeaux, 33000, France

  • CHU Bordeaux

    RECRUITING

    Bordeaux, 33000, France

  • CHU Caen

    RECRUITING

    Caen, 14000, France

  • CHU Dijon

    RECRUITING

    Dijon, 21000, France

  • CHU Gabriel Montpied

    RECRUITING

    Clermont-Ferrand, 63000, France

  • CHU Grenoble

    RECRUITING

    Grenoble, 38700, France

  • CHU Grenoble

    RECRUITING

    Grenoble, 38700, France

  • CHU Lille

    RECRUITING

    Lille, 59000, France

  • CHU Limoges

    RECRUITING

    Limoges, 87000, France

  • CHU Lyon sud

    RECRUITING

    Lyon, 69310, France

  • CHU Montpellier - St Eloi Hospital

    RECRUITING

    Montpellier, 34090, France

  • CHU Montpellier - rhumatology

    RECRUITING

    Montpellier, 34090, France

  • CHU Nancy

    RECRUITING

    Nancy, 54035, France

  • CHU Nantes

    RECRUITING

    Nantes, 44093, France

  • CHU Poitiers

    RECRUITING

    Poitiers, 86021, France

  • CHU Rouen

    NOT_YET_RECRUITING

    Rouen, 76000, France

  • CHU Saint Etienne

    RECRUITING

    Saint-Etienne, 42000, France

  • CHU Tours

    RECRUITING

    Tours, 37000, France

  • Cochin Hospital

    RECRUITING

    Paris, 75014, France

  • Henry Mondor hospital

    RECRUITING

    Créteil, 94000, France

  • Hopital L'Archet 1

    RECRUITING

    Nice, 06000, France

  • Hospital Croix St Simon

    NOT_YET_RECRUITING

    Paris, 75020, France

  • Hospital Pasteur - CHU Nice

    RECRUITING

    Nice, 06000, France

  • Hôpital Nord

    RECRUITING

    Marseille, 13015, France

  • Hôpital Sud

    RECRUITING

    Rennes, 35200, France

  • Hôpital de la Cavale Blanche

    RECRUITING

    Brest, 29200, France

  • Hôpitaux de Barbois

    RECRUITING

    Vandœuvre-lès-Nancy, 54500, France

  • La Pitié-Salpêtrière

    RECRUITING

    Paris, 75013, France

  • La Pitié-Salpêtrière

    RECRUITING

    Paris, 75013, France

  • La Timone Hospital

    RECRUITING

    Marseille, 13385, France

  • La Timone Hospital

    RECRUITING

    Marseille, 13385, France

  • Nouvel Hospital Civil

    RECRUITING

    Strasbourg, 67000, France

  • Rangueil Hospital

    RECRUITING

    Toulouse, 31400, France

  • Robert Debré Hospital

    RECRUITING

    Reims, 51100, France

  • Robert Schuman Hospital

    RECRUITING

    Metz, 57000, France

  • Saint Antoine Hospital

    NOT_YET_RECRUITING

    Paris, 75012, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.